Interestingly, administration of the antioxidant hormone melatonin reduced mitochondrial ROS damage and the consequent mtDNA release, thus ameliorating the cGAS-mediated neuroinflammation and increasing survival of a R6/2 mouse model of HD [87]. This evidence concerns the gene CGAS and Huntington disease.